Last month I reported that International Society for Stem Cell Research meeting in Toronto was to be the site for a report about research from Texas research firm, Pharmafronteirs. The July 6th issue of Nature has a News article on an announcement of the discovery of one way to cause adult cells to become embryo-like … Continue reading
>Last month I reported that International Society for Stem Cell Research meeting in Toronto was to be the site for a report about research from Texas research firm, Pharmafronteirs. The July 6th issue of Nature has a News article on an announcement of the discovery of one way to cause adult cells to become embryo-like … Continue reading
With the sexy title, “Virgin Birth Stem Cells Bypass Ethical Objections,” today’s on-line New Scientist is hyping the possibility of producing embryonic stem cells from induced parthenogenesis, the stimulation of an oocyte (or “egg”) to begin dividing to produce an embryo. The flawed reasoning is that, since these embryos are short lived and do not … Continue reading
>With the sexy title, “Virgin Birth Stem Cells Bypass Ethical Objections,” today’s on-line New Scientist is hyping the possibility of producing embryonic stem cells from induced parthenogenesis, the stimulation of an oocyte (or “egg”) to begin dividing to produce an embryo. The flawed reasoning is that, since these embryos are short lived and do not … Continue reading
Harvard alumnus James L. Sherley, M.D., Ph.D., a professor in the Biological Engineering department at Massachusetts Institute of Technology, has “come out” with his opposition to cloning and destructive embryonic stem cell research. In particular, Professor Sherley, a Pew scholar credited with research on the “assymetrical” division of adult stem cells, is quoted in Australia’s … Continue reading
Harvard alumnus James L. Sherley, M.D., Ph.D., a professor in the Biological Engineering department at Massachusetts Institute of Technology, has “come out” with his opposition to cloning and destructive embryonic stem cell research. In particular, Professor Sherley, a Pew scholar credited with research on the “assymetrical” division of adult stem cells, is quoted in Australia’s … Continue reading
The New Scientist is reporting the announcement (available by subscription here and the full, free version is here) by Pharmafrontiers (which is officially “Opexa Therapeutics.”) that the company has successfully de-differentiated human blood cells into stem cells that are usually thought to be from other cell lineages. In other words, Pharmafrontiers, “claims to have refined … Continue reading
>The New Scientist is reporting the announcement (available by subscription here and the full, free version is here) by Pharmafrontiers (which is officially “Opexa Therapeutics.”) that the company has successfully de-differentiated human blood cells into stem cells that are usually thought to be from other cell lineages. In other words, Pharmafrontiers, “claims to have refined … Continue reading
The National Review Online (please note today’s DBD cartoon) features correspondence between Eric Cohen, Jonathan Moreno, and Sam Berger, concerning Mr. Cohen’s article from May on the Castle-DeGette bill and the loosening the funding restrictions on destructive embryonic research. I am surprised that Moreno/Berger warn, “. . . politicized discussions of scientific issues are likely … Continue reading
>The National Review Online (please note today’s DBD cartoon) features correspondence between Eric Cohen, Jonathan Moreno, and Sam Berger, concerning Mr. Cohen’s article from May on the Castle-DeGette bill and the loosening the funding restrictions on destructive embryonic research. I am surprised that Moreno/Berger warn, “. . . politicized discussions of scientific issues are likely … Continue reading